[From the NHLBI Website]

Charting our future together: NHLBI’s Strategic Visioning Process

 

You may want to consider providing feedback on the NIH proposed Clinical Trials Registration rule. The deadline has been extended to March 23, 2015. To view the release and make comments, click here.

Xiang-An Li, Ph.D., of the University of Kentucky Saha Cardiovascular Research Center and Department of Pediatrics, has been awarded a $3 million grant from the National Institutes of Health to study synthetic HDL (sHDL) as a potential therapy for sepsis. Sepsis -- also called septicemia -- is a life-threatening condition caused by an overwhelming immune response to infection. Immune chemicals released by the body into the bloodstream to fight the infection trigger widespread inflammation that can damage multiple organ systems.
Governor Steve Beshear, joined by legislative leaders, today signed legislation authorizing construction of a multidisciplinary research building at the University of Kentucky. House Bill 298 provides for a state-of-the-art facility which will house world-class research across health disciplines. Research will focus on the many health challenges facing the Commonwealth, particularly those which contribute to preventable diseases and deaths. “This project represents the potential to improve the lives of so many, both within Kentucky where our health outcomes are so poor, and beyond,” Gov.

Join us on this memorable day and share in the excitement for our graduates. The Graduation Ceremony will be held on Saturday, May 16 at 1:30 p.m. in the Concert Hall of the Singletary Center for the Arts located at 405 Rose Street. This event is free and open to the public. There will be a reception following the ceremony. 

LEXINGTON, Ky. (March 9, 2015) — A trip to the school library in Paris, France set the foundation for a love story that spans nearly 30 years and two continents.

Elodie Elayi, and her husband, Samy-Claude Elayi were born, raised and educated in France.  

To date, a cure for Parkinson's disease remains elusive for the more than 50,000 Americans diagnosed yearly, despite decades of intensive study. But a newly approved treatment that might help ease the symptoms of Parkinson's has shown remarkable promise. Parkinson’s is a progressive disease caused by the death of dopamine-producing cells in the brain.
Nathan Vanderford, assistant director for research at the University of Kentucky Markey Cancer Center and assistant professor in the Department of Toxicology and Cancer Biology, has a featured article on graduate education in the March 5 edition of Nature. Nature is one of the most prominent and prestigious interdisciplinary scientific journals in the world. Vanderford co-wrote an article titled, "Wanted: Information" with Viviane Callier from the Ronin Institute for Independent Scholarship.

The AAMC report can be found at this link:    

https://www.aamc.org/newsroom/newsreleases/426166/20150303.html